Based in Cambridge, MA, BioNTech US
serves as BioNTech’s North American headquarters and is an important part of our global effort to pioneer the development of next-generation immuno-oncology therapies. BioNTech US is a fully integrated subsidiary with a strong foundation in Europe and a focus on the development of novel neoantigen-targeted T cell therapies, complementing BioNTech’s highly innovative scientific approach and diversified pipeline of transformative cancer medicines. As a key research and clinical development hub, BioNTech US will enable BioNTech’s growing presence in the US.
The (Senior) Medical Director – Infectious Diseases is recognized within BioNTech as the ‘program lead’ for one or more assets entering clinical development phase. The medical director will have multiple opportunities to lead the design and execution of development strategies, from pre-IND to NDA and will work closely with exceptional preclinical and clinical scientists in implementing these development plans. There is extensive opportunity for interactions with the Company’s senior management, and externally with highly-recognized clinical investigators in the US and throughout the world.